用斯佩索利马布有效管理危及生命的泛性皮质银病爆发
Efterpi Zafiriou1, Emmanouil Karampinis1, George Giannoulis2
1Department of Dermatology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Larissa, GRC.
Cureus
|August 13, 2024
概括
泛性性牛皮 (GPP) 是严重的和不可预测的. 作为IL-36受体对抗剂的斯佩索利马布有效治疗了对其他疗法的严重GPP爆发,显示了针对性GPP管理的希望.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 泛性性牛皮 (GPP) 是一种严重的,不可预测的皮肤疾病,其特点是和炎症.
- GPP爆发可能导致危及生命的并发症,严重病例需要快速有效的治疗.
- 干白素-36 (IL-36) 在GPP病理生理学中起着关键作用.
研究的目的:
- 介绍一个患有严重的,耐治疗的GPP爆发的患者的案例研究.
- 评估一种IL-36受体对抗剂斯佩索利马布在治疗严重GPP时的疗效.
- 突出针对GPP的向治疗的潜力.
主要方法:
- 一份病例报告显示,一名48岁的男性患有广泛的GPP爆发和全身症状.
- 最初使用阿西特雷丁和阿纳金拉的治疗没有成功.
- 与阿西特雷丁一起使用斯佩索利马布 (IL-36受体对抗剂) 进行治疗.
主要成果:
- 患者经历了快速改善,瘤和皮肤炎症的解决.
- 斯佩索利马布治疗导致从严重的GPP爆发中逐渐恢复.
- 患者还在治疗期间管理了包括抑郁症和肺栓塞在内的并发症.
结论:
- 斯佩索利马布显示出作为针对性治疗严重的GPP爆发的潜在潜力,这些爆发对传统治疗不耐药.
- 这一案例支持IL-36通路抑制在GPP管理中的作用.
- 需要进一步的研究来确认spesolimab在GPP中的长期安全性和有效性.
更多相关视频
相关概念视频
01:26Peptic Ulcer Disease IV: Management
79
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
79
01:28Pleural Effusion II: Symptoms and Management
160
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
160
01:29Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
109
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
109
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
124
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124